Document is current
Any future updates will be listed below
-
Authors
Ho, Calvin N. https://orcid.org/0000-0002-3360-9651
Kündig, Anna
Bahadori, Lila
Roat, Katy
Bruce, Rachel
Goswami, Caroline P.
Kelly, Kimberly
Moll, Thomas
-
Funding
Funding for this research was provided by:
AstraZeneca
- License Information
-
More Information
Article History
Received: 6 June 2024
Accepted: 2 December 2024
First Online: 18 December 2024
Declarations
:
: This study was conducted in accordance with the ethical principles that have their origin in the Declaration of Helsinki and that are consistent with Good Clinical Practice and applicable regulatory requirements. Independent institutional review for this study was provided by WCG (WIRB-Copernicus Group) IRB (Tracking Number: 20230164), and all participants consented to participate in this research via signed informed consent.
: No patient-identifiable data have been presented. Informed consent stipulated that if the results of this study are published, no patient will be identified.
: CNH, LB, and AK are employees of AstraZeneca and may own stock/stock options. KR, KK, RB, and CPG are employees of IQVIA, which received funding from AstraZeneca to conduct this study. TM is an employee of Clario, which received funding from AstraZeneca to (1) create the electronic build for the study and (2) supply the devices.
